These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27504665)

  • 1. In Vitro Evaluation of CRISPR/Cas9 Function by an Electrochemiluminescent Assay.
    Liu W; Yu H; Zhou X; Xing D
    Anal Chem; 2016 Sep; 88(17):8369-74. PubMed ID: 27504665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
    Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
    PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of application and off-target effects of CRISPR/Cas9.
    Zheng W; Gu F
    Yi Chuan; 2015 Oct; 37(10):1003-10. PubMed ID: 26496752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatic Improvement of CRISPR/Cas9 Editing in
    Ng H; Dean N
    mSphere; 2017; 2(2):. PubMed ID: 28435892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient genome editing by CRISPR/Cas9 with a tRNA-sgRNA fusion in the methylotrophic yeast Ogataea polymorpha.
    Numamoto M; Maekawa H; Kaneko Y
    J Biosci Bioeng; 2017 Nov; 124(5):487-492. PubMed ID: 28666889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
    Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
    Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New applications of CRISPR/Cas9 system on mutant DNA detection.
    Jia C; Huai C; Ding J; Hu L; Su B; Chen H; Lu D
    Gene; 2018 Jan; 641():55-62. PubMed ID: 29031777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.
    Anderson EM; Haupt A; Schiel JA; Chou E; Machado HB; Strezoska Ž; Lenger S; McClelland S; Birmingham A; Vermeulen A; Smith Av
    J Biotechnol; 2015 Oct; 211():56-65. PubMed ID: 26189696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
    Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
    BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
    Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
    Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.
    Wang X; Wang Y; Wu X; Wang J; Wang Y; Qiu Z; Chang T; Huang H; Lin RJ; Yee JK
    Nat Biotechnol; 2015 Feb; 33(2):175-8. PubMed ID: 25599175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA fragment editing of genomes by CRISPR/Cas9.
    Li JH; Shou J; Wu Q
    Yi Chuan; 2015 Oct; 37(10):992-1002. PubMed ID: 26496751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted genome modifications in soybean with CRISPR/Cas9.
    Jacobs TB; LaFayette PR; Schmitz RJ; Parrott WA
    BMC Biotechnol; 2015 Mar; 15():16. PubMed ID: 25879861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.